Figure 2.
Figure 2. QOL-E domains at baseline and 12 weeks between Arm A (eltrombopag) and Arm B (placebo)

QOL-E domains at baseline and 12 weeks between Arm A (eltrombopag) and Arm B (placebo)

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal